biomedicina slovenica


"Interferons" : 101

  1. Chen Jianzhou; Markelc Boštjan; Kaeppler Jakob; Ogundipe Vivian M. L.; Cao Yunhong; McKenna Gillies W.; Muschel Ruth J.
    STING-dependent interferon-[lambda]1 induction in HT29 cells, a human colorectal cancer cell line, after gamma-radiation
    2018
  2. Resman Rus Katarina; Korva Miša; Bogovič Petra; Pal Emil; Strle Franc; Avšič-Županc Tatjana
    Delayed interferon type 1-induced antiviral state is a potential factor for hemorrhagic fever with renal syndrome severity
    2018
  3. Goropevšek Aleš; Gorenjak Maksimiljan; Gradišnik Suzana; Dai Klara; Holc Iztok; Hojs Radovan; Krajnc Ivan; Pahor Artur; Avčin Tadej
    Increased levels of STAT1 protein in blood CD4 T cells from systemic lupus erythematosus patients are associated with perturbed homeostasis of activated homeostasis of activated CD45RA-FOXP3hi regulatory subset and follow-up disease severity
    2017
  4. Vianna Garcia Patrick; Ferreira Seiva Fábio Rodrigues; Pocol Carniato Amanda; de Mello Wilson; Durán Nelson; Macedo Alda Maria; Gabarra de Oliveira Alexandre; Romih Rok; da Silva Nunes Iseu; da Silva Nunes Odilon; Fávaro Wagner José
    Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer
    2016
  5. Šooš Eugen; Filipič Bratko; Miko Slobodan; Mazija Hrvoje
    Farmaceutski pripravak za pojačanje antiproliferativne i proapoptotske aktivnosti humanih interferona holocenskim mineralima
    [Pharmaceutical composition for increasing antiproliferative and proapoptotic activity of human interferons by holocene minerals]
    2015
  6. Goropevšek Aleš; Zakelšek Andrejka; Cencič Avrelija; Gorenjak Maksimiljan; Krajnc Ivan; Avčin Tadej
    T cells in systemic lupus erythematosus patients display characteristic signature of interferons in terms of high STAT1 expression
    2010
  7. Rot Uroš; Horvat-Ledinek Alenka
    Interferons beta have vasoconstrictive and procoagulant effects: a woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis
    2013
  8. Kärner J.; Trebušak Podkrajšek Katarina; Bratanič Nevenka; Battelino Tadej
    Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice
    2013
  9. Jaki Polona
    Uporaba bioloških zdravil za zdravljenje očesnih vnetij
    [The use of biologic therapies for the treatment of ocular inflammation]
    2012
  10. Kisand Kai; Link Maire; Wolff Anette S; Meager Anthony; Tserel Liina; Org Tonis; Murumagi Astrid; Trebušak-Podkrajšek Katarina; Battelino Tadej
    Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes
    2008
  11. Goropevšek Aleš; Homšak Evgenija; Gorenjak Maksimiljan; Malešič Ivan; Krajnc Ivan; Cencič Avrelija
    Novejši biooznačevalci in spremljenje znotrajceličnih signalnih poti pri avtoimunskih boleznih
    [New biomarkers and monitoring intracellular signaling pathways in autoimmune diseases]
    2008
  12. Matičič M; Poljak M; Lunder T; Rener-Sitar K; Stojanovič L
    Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
    2008
  13. Smilović Vanja
    Razvoj celične linije za določanje biološke aktivnosti interferonov
    [Development of cell line suitable for the determination of biological activity of interferons]
    2006
  14. Jurca Jože
    Osnove imunologije
    2003
  15. Stojanovič Larisa; Mlakar Boštjan
    Sodobni načini zdravljenja anogenitalnih bradavic
    [Current therapy for anogenital warts]
    2004
  16. Cencič Avrelija; Guillomot M; Koren Srečko; La Bonnardiere C
    Trophoblastic interferons: do they modulate uterine cellular markers at the time of conceptus attachment in the pig?
    2003
  17. Hafner Matjaž
    Nov pristop k zdravljenju kroničnega hepatitisa C
    2003
  18. Štepec Srečo
    Advances in the treatment of chronic viral hepatitis
    2003
  19. Schauer Primož; Hren-Vencelj Helena
    Prispevek k poznavanju mehanizma delovanja interferona: elektroforetska ločba interferonsko induciranega materiala
    [Contribution to understanding the mechanism of interferon activity: electrophoretic separation of interferon-induced material]
    1975
  20. Židanik Miloš
    Med boleznijo in upanjem: prikaz primera
    2002
  21. Brinovec Vladimir; Lešničar Gorazd
    Sodobno zdravljenje kroničnega hepatitisa B
    [Modern therapy for chronic hepatitis B]
    2002
  22. Marinko Petra; Krbavčič Aleš
    Imunogenost interferona: tehnično vrednotenje interferona alfa
    [Immunogenicity of interferon: technical evaluation of interferon alpha]
    2001
  23. Maraspin-Čarman Vera
    Uporaba protivirusnih zdravil v nosečnosti
    [The use of antiviral drugs in pregnancy]
    2001
  24. Schauer P; Suhar A; Škrk J; Likar M; Turk V
    The effect of interferons on the proteolytic activity of normal and transformed cells
    1983
  25. Korbelik M; Škrk J; Suhar A; Schauer P; Petrović D; Turk V
    The effects of proteinases, their inhibitors and interferons on repair of radiation-induced potentially lethal damage
    1985
  26. Korbelik M; Škrk J; Suhar A; Schauer P; Turk V
    The role of intra and extracellular proteinases, their inhibitors, interferons and hormones in proliferative activities of mammalian cells in culture
    1985
  27. Schauer P; Suhar A; Škrk J; Likar M; Turk V
    Effect of homologous and heterologous interferons on proteolytic activity of normal and transformed cells
    1983
  28. Filipič B; Schauer P; Likar M
    PURIFICATION OF LABELLED INTERFERONS
    1976
  29. Štabuc Borut
    Neželeni učinki hormonskih učinkovin in citokinov
    2000
  30. Fleischmann W Robert Jr; Koren Srečko
    Systemic effects of orally administered interferons and interleukin-2
    1999
  31. Filipič Bratko; Orešić K; Toth S; Koren Srečko
    Cytocidal activity of human and porcine alpha interferons on pla cells in vitro
    1999
  32. Filipič Bratko; Zorman-Rojs Olga
    Biological activity of interferons in the sera of commercial poultry flocks vaccinated under the standard immunoprophylactic programmes
    1999
  33. Stefanovska Voskresija; Gerasimova Pavlina; Blagoevska Milenka
    Uticaj leukodeplecije na imunomodulaciju
    1999
  34. Koren Srečko; Poljak Mario
    Kemoterapija virusnih bolezni
    1998
  35. Koren Srečko
    Naravna protivirusna odpornost
    1998
  36. Koren Srečko
    Interferoni - pomembni dejavniki v imunskem odzivu
    [Interferons - important factors in immune response]
    1998
  37. Bren Andrej F; Kandus Aljoša; Ferluga Dušan
    Interferon-alpha associated rapidly progressive renal graft failure in patient with chronic myelogenaus leukemia
    1998
  38. Škrbec Miha
    Vrijednost kompjutorizirane tomografije u bolesnika s malignim gliomom liječenih interferonom
    1996
  39. Rudolf Z; Furlan L
    Adjuvant treatment of malignant melanoma with human leukocyte interferon
    1990
  40. Štabuc Borut
    Zdravljenje raka z modifikatorji biološkega odziva
    1996
  41. Rudolf Z
    Novi pristopi v kombiniranem zdravljenju solidnih tumorjev s preoblikovalci biološkega odgovora - interferon pri malignem melanomu
    1996
  42. Eberl-Gregorič E; Filipič B; Rozman S; Cencič A; Drinovec B
    Porcine interferon-gamma inhibits the growth of Legionella pneumophila in WiREF cells in vitro
    1996
  43. Filipič Bratko
    Živalske tkivne kulture
    1996
  44. Koren S; Fleischmann RW Jr
    Circadian coordination of the IFN system
    1996
  45. L'Haridon R
    Monoklonska protitelesa: produkcija in možnosti njihove uporabe za karakterizacijo in čiščenje interferonov
    1995
  46. Koren S; Fleischmann WR Jr
    Sistemsko učinkovanje oralno apliciranih citokinov
    [Systemic effects of orally administered cytokines]
    1995
  47. Katona I; Toeroek L; Serenyi P
    Cystic Kaposi's sarcoma
    1995
  48. Cenčič A
    Prašičji imunski interferon
    [Porcine immune interferon]
    1995
  49. Kotnik V; Čižek-Sajko M; Ihan A; Simčič S; Wraber B; Štalc A
    Natural and artificial immunomodulation
    [Naravna in umetna imunomodulacija]
    1994
  50. Serša G
    Tumor necrosis factor - biological characteristics and applications in cancer therapy
    [Tumorski nekrozni faktor - biološke značilnosti in protitumorsko delovanje]
    1994
  51. Koren S; Fleischmann WR Jr
    Chronobiology of the interferon system
    [Kronobiologija interferonskega sistema]
    1994
  52. Mažuran R
    The role of interferons in the regulation of cell function and the pathogenesis of disease
    [Vloga interferonov pri uravnavanju delovanja in patogenezi bolezni]
    1994
  53. Fleischmann WR Jr
    Interferons in antitumor therapy: current status and future prospects
    [Interferoni pri zdravljenju tumorjev: stanje danes in izgledi za prihodnost]
    1994
  54. Koren S; Fleischmann WR Jr
    Modulation of peripheral leukocyte counts and bone marrow function in mice by oral administration of interleukin-2
    1994
  55. Korošec L
    Zdravljenje virusnih bolezni
    1994
  56. Filipič B; Golob A; Struna T; Likar M
    Porcine mitogen-induced interferon
    1994
  57. Fleischmann WR Jr; Koren S
    The use of combination therapies to enhance interferon action
    1987
  58. Koren S; Fleischmann WR Jr
    Orally administered interferons suppress bone marrow function (43646)
    1993
  59. Duc-Goiran P; Robert B; Navarro S; Lopez J; Chavinie J; Ferre F; Chany C; Doly J
    Type I interferons spontaneously expressed during human pregnancy
    1993
  60. Rudolf Z
    Adjuvant treatment of malignant melanoma with human leukocyte interferon after radical surgery. 1. general analysis
    1993
  61. Rudolf Z; Kotnik V; Vozelj M
    Klinička imunologija u SR Sloveniji
    1990
  62. Koren S; Whorton EB Jr; Fleischmann WR Jr
    Circadian dependence of interferon antitumor activity in mice
    1993
  63. Eberl-Gregorič E
    Vpliv humanih in humanim podobnih interferonov na bakterijo Legionella pneumophila
    1993
  64. Koren S; Fleischmann WR Jr
    Circadian variations in myelosuppressive activity of interferon-alpha in mice: identification of an optimal treatment time associated with reduced myelosuppressive activity
    1993
  65. Pretnar G; Filipič B; Golob A; Škodič A; Toth S; Mecs I; Suhar A
    Electroinduction of interferon-like proteins
    1991
  66. Fleischmann WR; Koren S; Fleischmann CM
    Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism (43499)
    1992
  67. Vozelj M; Kotnik V; Wraber B; Koren S; Simčič S; Klampfer L; Ihan A
    Imunomodulatorji in imunomodulacija
    1989
  68. Baršić B
    Antivirusna terapija
    [Antiviral therapy]
    1991
  69. Bobnar A
    Zdravstvena nega bolnika, zdravljenega z imunomodulatorji in kemoterapevtiki
    1990
  70. Jereb B
    Kombinovana terapija malignog astrocitoma
    1990
  71. Rudolf Z
    Onkologija - problemi in perspektive
    1989
  72. Koren S
    Interferoni in virusne okužbe
    1989
  73. Hren-Vencelj H
    Antivirusne spojine
    1989
  74. Koren S
    Interferoni in imunski odziv
    [Interferons and the immune response]
    1990
  75. Rudolf Z
    Klinična imunologija v Sloveniji - kratek prikaz razvoja in prioritetnih področij raziskav
    [Clinical immunology in Slovenia - short review of historical development and research priorities]
    1990
  76. Rudolf Z
    Onkologija - problemi in perspektive
    [Oncology - problems and future prospects]
    1989
  77. Korbelik M; Škrk J; Suhar A; Turk V
    The role of proteinases, interferons and hormones in proliferative activities of nonmalignant and malignant cells
    1988
  78. Drinovec B
    6. kongres mikrobiologov Jugoslavije: zbornik povzetkov
    1989
  79. Štrukelj B
    Plazmidi in gensko načrtovanje
    [Plasmids and genetic engineering]
    1988
  80. Vozelj M; Kotnik V; Koren S; Wraber-Herzog B; Simčič S; Dežman M; Klampfer L
    Vpliv imunomodulatorjev na funkcije fagocitnih celic
    [Influence of the immunomodulations on the functions of macrophages]
    1986
  81. Koren S
    Interakcije različnih interferonskih vrst glede na njihovo protitumorsko delovanje
    [Interaction of different interferon types regarding their antitumor activity]
    1986
  82. Filipič B; Likar M; Keše D; Koren S; Marin J; Rednak M
    Protitumorsko delovanje interferona
    [Antitumor activity of interferon]
    1986
  83. Koren S; Fleishmann WR jr
    Antitumorsko delovanje interferonskih kombinacija
    [Antitumor effect of interferon combinations]
    1988
  84. Keše D
    Vpliv interferona na delovanje nevtralnih proteinaz in vitro
    1988
  85. Filipič B; Schauer P; Keše D; Likar M
    Effect of interferon on the phospholipids and cholesterol in nontransformed and transformed cells
    1986
  86. Hren-Vencelj H; Filipič B
    Kemoterapija
    1986
  87. Kutllovci M; Dreshaj Sh; Blakaj M; Tolaj I
    Racionalna antivirusna terapija
    1987
  88. Konstantinović Lj; Soldatović K; Konstantinović S; Kostić V; Ranković Ž; Krstić M; Stanišić S; Aleksov Lj
    Primena alfa interferona i leproteka u VHB infekciji
    1987
  89. Groza Š; Delić D; Švirtlih N
    Terapija hroničnog aktivnog B-hepatitisa
    1987
  90. Mudrić V
    Virusni hepatitisi
    1987
  91. Keše D; Schauer P; Škrk J; Suhar A; Marin J; Likar M; Turk V
    Influence of proteinases on interferon in vitro
    1986
  92. Koren S; Fleischmann WR Jr
    Quantitation of in vivo potentiation resulting from combined interferon therapy: antitumor effect against B-16 melanoma in mice
    1986
  93. Koren S; Klimpel GR; Fleischmann WR Jr
    Treatment of mice with macrophage colony stimulating factor (CSF-1) prevents the in vivo myelosuppression induced by murine alpha, beta, and gamma interferons
    1986
  94. Koren S; Klimpel GR; Fleischmann WR Jr
    Macrophage colony stimulating factor (CSF-1) blocks the myeloid suppressive but not the antiviral or antiproliferative activities of murine alpha, beta, and gamma interferons in vitro
    1986
  95. Kotnik V
    Vpliv topnih produktov aktiviranih limfocitov na naravne celice ubijalke
    1986
  96. Rudolf Z
    Treatment of malignant melanoma with human leukocyte interferon-preliminary results of randomized trial
    1986
  97. Jereb B; Petrič G; Tekavčič I; Škrbec M; Bilban-Jakopin C
    Intratumor application of human leukocyte interferon (HLI) in patients with malignant brain tumors
    1986
  98. Škrk J; Korbelik M; Suhar A; Turk V; Filipič B; Kotnik V; Likar M
    The effects of interferons on transformation of human lymphocytes
    1986
  99. Korbelik M; Škrk J; Suhar A; Filipič B
    Interferons as stimulatory as well as inhibitory agents in cell proliferation and repair of radiation-induced potentially lethal damage
    1986
  100. Filipič B; Keše D; Likar M
    Monoclonal antibodies against rat fibroblast interferon I: preliminary characterisation of hybridomas and clones
    1986

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics